@VertexPharma profile picture
Vertex Pharmaceuticals @VertexPharma

The official channel for Vertex Pharmaceuticals. bit.ly/3Bvj6WE

Joined November 2008
  • Tweets 3,567
  • Following 83
  • Followers 70,059
1,615 Photos and videos
We presented data on our gene-edited therapy for people with sickle cell disease or transfusion-dependent beta thalassemia at the European Hematology Association (EHA) Congress and announced regulatory submissions for potential future use in additional patients. Find out more: vrtx.com/en-global/ We’re grateful to the researchers, clinicians, and patients whose contributions help move the science forward. #EHA2026
3
571
Extended reimbursement agreement with National Health Insurance Fund in #NorthMacedonia: Since May 20, 2026, eligible people living with #CysticFibrosis ages 2 years and older have broad access to one of our medicines.
1
2
497
We are proud to announce that the U.S. FDA has accepted our Biologics License Application (BLA) for our investigational therapy for #IgANephropathy. Learn more: news.vrtx.com/news-releases/…
2
3
10
1,029
First reimbursement agreement in #Chile: Eligible people living with #CysticFibrosis now have reimbursed access to one of our #CysticFibrosis therapies.
6
1
8
1,329
Major update for the treatment of cystic fibrosis (CF) in the U.S.: The FDA has approved the label extension for our triple combination therapies, expanding availability of these medicines to ~95% of all people with CF in the U.S. Learn more: news.vrtx.com/news-releases/…
4
7
13
1,703
We’re excited to share positive topline results from the interim analysis of the RAINIER Phase 3 study of our investigational therapy for #IgANephropathy. Learn more: news.vrtx.com/news-releases/…
1
3
11
1,732
We’re pleased to share results from the Phase 4 study of our non‑opioid treatment for moderate‑to‑severe acute pain, presented at the American Academy of Pain Medicine (AAPM) PainConnect 2026 meeting: news.vrtx.com/news-releases/…
1
2
11
1,189
Announcing a reimbursement agreement with the Italian Medicines Agency (AIFA) for access to our latest cystic fibrosis (CF) therapy for eligible patients 6 years and older and expanded access to two of our other medicines for eligible patients 2 years old and older.
3
2
6
1,227
Vertex is committed to the safety and security of all job seekers. If you receive suspicious recruitment messages or believe you have been targeted by a recruitment scam, do not respond or provide any information. Learn how to identify recruitment scams: vrtx.com/beware-recruitment-…
2
1
8
1,643
We have entered a new reimbursement agreement for our latest #CysticFibrosis (CF) therapy in #Bulgaria. This new agreement has enabled broad access for eligible people living with CF ages 6 years and older since Jan 5, 2026.
0:15
4
7
2,098
Extended reimbursement agreement with the Croatian health authorities: Since Dec 30, 2025, eligible children living with #CysticFibrosis ages 1 year and older have had broad access to some of our medicines.
2
1
6
1,422
We are pleased to share new data from multiple studies of our gene-edited therapy for sickle cell disease and transfusion-dependent beta thalassemia at the 67th ASH Annual Meeting this weekend. Learn more: news.vrtx.com/news-releases/… #ASH25
3
5
17
2,320
Extended reimbursement agreement with the health authorities of #Slovakia: eligible people living with #CysticFibrosis ages 2 year and older will now have broad access to one of our medicines.
4
7
1,908
We're excited to share several advancements across our investigational programs for the potential treatment of IgA nephropathy (IgAN), APOL1-mediated kidney disease (AMKD) and autosomal dominant polycystic kidney disease (ADPKD). Learn more: investors.vrtx.com/news-rele…
5
16
2,755
#Breaking: Today Health Canada granted marketing authorization for our fifth cystic fibrosis (CF) medicine.
0:15
22
4
28
3,992
We are proud to announce that our acute pain medicine has been recognized as a 2025 Breakthroughs Innovation Celebration winner by @PremierHA, a leading healthcare improvement company. Learn more: news.vrtx.com/news-releases/…
0:20
13
4
32
3,794
Today the European Commission approved our fifth cystic fibrosis (CF) medicine. This marks an important step towards our goal of treating all people with CF.
0:15
3
5
38
3,868
We are excited to share that data for our investigational stem cell-derived, fully differentiated islet cell therapy for #Type1Diabetes were published in @NEJM. Learn more: nejm.org/
3
7
54
4,716
#Breaking: Today we announced updated data for our investigational islet cell therapy for the treatment of #Type1Diabetes. Learn more: news.vrtx.com/news-releases/…
5
28
96
98,080
Extended reimbursement agreement with the health authorities of #Slovenia: eligible children living with #CysticFibrosis ages 1 year and older will now have broad access to some of our medicines.
9
3
12
2,749
Load more